Oncolytics Biotech faces financial struggles and unclear pelareorep efficacy signals. Learn why ONCY stock's risks outweigh ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Biotech companies make some of the best growth stocks. These firms are at the forefront of medical advances such as gene ...

A company presentation will take place during the conference’s Innovation track on Friday, March 28th at 9:00am. NeauxCancer conference’s Innovation track spotlights the most promising emerging ...

Organovo’s stock skyrocketed 244% Tuesday on the news ... thought to hold potential across several gastrointestinal (GI) diseases. However, the drug class has faced several setbacks, namely ...

Proficio Capital Partners LLC purchased a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 35, ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Detailed price information for New York Times Company (NYT-N) from The Globe and Mail including charting and trades.

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday ...